Navigation Links
Zyngenia, Inc. Raises $10 Million in Series A Funding
Date:11/4/2009

e of Chemical Biology and the Departments of Molecular Biology and Chemistry at The Scripps Institute, La Jolla, California. Dr. Barbas is renowned for his work in peptides and proteins, antibodies and chemically programmed antibodies. He has particular expertise in novel antibody technologies and was a founder of two successful antibody platform companies, Cov-X Pharmaceuticals (acquired by Pfizer) and Prolifaron (acquired by Alexion).

Zyngenia's founding management team also includes Joseph Amprey, M.D., Ph.D., former head of MedImmune Ventures, Inc., as Chief Business Officer. Dr. Amprey joined MedImmune Ventures as the first full-time employee and helped grow the portfolio from 13 investments to 28. He led 11 deals during his time at MedImmune Ventures and served on five boards. Recently, David Hilbert, Ph.D., has been appointed the Vice President and Head of Research and Development. Dr. Hilbert formerly served as Vice President of Research at both Cellective Therapeutics and Human Genome Sciences. Dr Hilbert led Research and Development at Cellective until its acquisition by MedImmune in 2005. At Human Genome Sciences, Dr Hilbert led the transformation of the company from a genomics research company to an integrated drug development organization. His expertise in oncology, autoimmunity and antibody development enabled the first IND for the company and was pivotal in the development of ABthrax and Benlysta.

In conjunction with the Series A financing, David M. Mott, NEA General Partner, will become Chairman of the Board. Robert Garland, M.D., Partner at NEA, will also join the company's board of directors. Mr. Mott focuses on biopharmaceutical investments at NEA. He is Chairman of 3-V Biosciences, a Director of Ardelyx and Zosano Pharma, and serves on the advisory board of the Scripps Translational Science Institute. Prior to joining NEA, he was President and CEO of MedImmune, which was acquired by AstraZeneca for $15.6 billion in 20
'/>"/>

SOURCE Zyngenia, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Pearl Therapeutics Raises $15.5 Million in Private Financing
2. Enobia Pharma Raises $40.1 Million Series B Financing
3. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
4. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
5. VisEn Medical Raises $7 Million in Series B Financing
6. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
9. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance
10. Anesiva Raises $45 Million in Common Stock Offering
11. Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Through science fairs, workshops, kits for building optical ... organizations will continue their work to increase awareness about ... daily life with the aid of SPIE Education ... countries, are the first of two groups of recipients ... international society for optics and photonics , in 2013. ...
(Date:5/21/2013)... , May 21, 2013 The ... and Transplant Association) is the biggest congress in ... therapy. Nearly 10,000 participants are in Istanbul ... latest research findings. New pioneering studies have been presented: ... FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Smarter Security, ... security solutions, today announced that Genzyme, a Sanofi company ... of Door Detective® CL for a multi-use facility in ... in four other Genzyme buildings, this latest order underscores ... the tailgate detection device improving doorway access ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Many have ... as contributor to acne. Recently physicians from Clinical ... mental stress on the skin, and suggested using ... reduce the chemicals produced from stress that cause acne. ... the negative feelings acne brings about, stress causes changes ...
Breaking Biology Technology:Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2
... law in New Jersey could be sign of things ... about workplace violence,is nowhere more acute than among healthcare ... to become the target of on-the-job violence than,their counterparts ... of horrific headlines, healthcare facilities understandably face,mounting pressure to ...
... RICHMOND, Va., July 9 Insmed Inc. (Nasdaq:,INSM), a ... Glover, President Insmed Therapeutics, will present at the,Collins Stewart ... 10:30 AM ET, in New York., The conference ... New,York City, from Tuesday, July 8 through Thursday, July ...
... -- Dr. Fernando Perez-Ruiz Joins Ardea,s Inflammatory Disease Scientific ... ... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) today announced that it has ... RDEA806 in gout,patients with hyperuricemia. Gout, also known as metabolic arthritis, ...
Cached Biology Technology:Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney 2Insmed to Present at Collins Stewart Fourth Annual Growth Conference 2Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout 2Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout 3Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout 4
(Date:5/17/2013)... 18, 2013) The AGA Research Foundation announced a ... relationship between the gut microbiota, one of today,s most ... , The AGA Research Awards Panel selected Andrew ... General Hospital and Harvard Medical School, Boston, as the ... Chan will receive $25,000 of funding, commencing in July ...
(Date:5/17/2013)... New Jersey, and City University of New York have ... that effectively clears organisms to be viewed under microscopes. ... which is one of the few high-quality clearing solutions ... Drug Enforcement Administration (DEA) due to its use as ... vital for viewing organisms under a microscope. Without them, ...
(Date:5/17/2013)... the interaction of a group of proteins in the ... identified a new target that could increase cell survival. ... School of Biochemistry and published in the EMBO ... eventually lead to new therapies for stroke and other ... by the team which identified a protein, known as ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3SUMO wrestling cells reveal new protective mechanism target for stroke 2
... is available in Spanish . , ... nematodes could improve the delivery, timing and use of ... machine is the result of a cooperative research and ... and Southeastern Insectaries, Inc., of Perry, Ga. The ...
... The Association for Molecular Pathology (AMP) opposed the ... the subject matter of a cancer-related proteonomics patent application ... submitted to NIH in response to a request for ... of Exclusive License: The Development of a Companion Diagnostic ...
... has no effect on the presence of large mammals in ... time compares the biological diversity of ecotourism zones with that ... biodiversity of areas that are not officially protected yet are ... to promote ecological tourism at the end of the 1980,s ...
Cached Biology News:Special delivery: Nematode-infected insect cadavers 2AMP opposes exclusive licensing of NIH proteomics patent 23 researchers in the Amazon clear up doubts as to the benefits of ecotourism 23 researchers in the Amazon clear up doubts as to the benefits of ecotourism 3
... for whole-blood clinical diagnostic work in hospitals ... this analyzer makes precise glucose measurements of ... lactate measurements of whole blood, plasma, or ... allows you to have glucose results expressed ...
... Cleanroom-grade vinyl curtains or ... powder-coated steel support frame to ... cleanroom that meets cleanliness to ... HEPA filter/fan units, lights, and ...
... BioSafe room is configured specifically for ... chemical analysis. Panels are precision-joined to ... to wipe down and disinfect. One-inch ... panel design creates strong, rigid surface ...
... The Varian 500-MS LC Ion Trap ... high-throughput LC/MS analysis where sensitivity, reliability ... 500-MS provides a robust platform for ... mass resolution, and mass stability reflect ...
Biology Products: